Fresenius Medical Care AG (FMS) Cost of Revenue (2009 - 2026)

Fresenius Medical Care AG's Cost of Revenue history runs 18 years deep, the most recent figure standing at $4.0 billion for Q1 2026.

• In Q1 2026, Cost of Revenue rose 3.33% year-over-year to $4.0 billion; the TTM figure through Mar 2026 stood at $16.6 billion (up 5.06% YoY), while the FY2025 annual figure was $17.0 billion, up 9.08% from the prior year.
• Cost of Revenue for Q1 2026 stood at $4.0 billion, down from $4.3 billion in the prior quarter.
• The five-year high for Cost of Revenue was $4.3 billion in Q4 2025, with the low at $1.0 billion in Q3 2022.
• The 5-year median for Cost of Revenue is $3.9 billion (2025), against an average of $3.1 billion.
• The sharpest annual moves came in 2022 and 2023: Cost of Revenue decreased 8.73% in 2022, then surged 279.82% in 2023.
• Fresenius Medical Care AG's Cost of Revenue stood at $1.1 billion in 2022, then surged by 265.39% to $3.9 billion in 2023, then grew by 4.12% to $4.1 billion in 2024, then gained by 5.13% to $4.3 billion in 2025, then slipped by 6.21% to $4.0 billion in 2026.
• Business Quant data shows FMS's Cost of Revenue at $4.0 billion in Q1 2026, $4.3 billion in Q4 2025, and $4.3 billion in Q3 2025.